labiotech.eu

Root domain: labiotech.eu The root domain (apex) without subdomains OVH SAS

Registrar

OVH SAS

Updated 9 days ago

registered

Domain Status

registered

ns-462.awsdns-57.com +3

Nameservers

ns-462.awsdns-57.com

ns-1592.awsdns-07.co.uk

ns-1325.awsdns-37.org

ns-868.awsdns-44.net

Updated 9 days ago

Keywords

Currently ranking

Unique keywords

High value

> $100 / month

Estimated Traffic

How is this calculated?

Estimated traffic is calculated using:

Search Volume × CTR (by position)

CTR varies by position:

Position 1: 30%
Position 2: 15%
Position 3: 10%
Positions 4-10: Decreasing rates
Position 11+: 0.5%

Monthly visits

Across all rankings

Traffic value

$31.64

Estimated monthly

Activity

Last seen

Jan 08

8 days ago

First seen

Jan 06, 2026

9 days ago

Keyword rankings

Showing 1-3 of 3 rankings

Show:

Keyword / Page	Position	Estimated Traffic How is this calculated? Estimated traffic is calculated using: Search Volume × CTR (by position) CTR varies by position: Position 1: 30% Position 2: 15% Position 3: 10% Positions 4-10: Decreasing rates Position 11+: 0.5%	Estimated Traffic Value How is this calculated? Estimated traffic value is calculated using: Estimated Traffic × CPC This represents the estimated monthly value of the traffic based on the keyword's cost-per-click (CPC) from Google Ads data.	Last Seen	Actions
cure als ALS: how close are we to a cure? /in-depth/als-cure-biotech-review/	3 Best: 3 • Worst: 3	7 visits/month	$30.24 monthly value	8 days ago	Search Profile 🇸🇪 Sweden Mobile ALS: how close are we to a cure? /in-depth/als-cure-biotech-review/ 25 juni 2025 — The hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past decade, with six drugs approved by American regulators.
als treatment ALS: how close are we to a cure? /in-depth/als-cure-biotech-review/	7 Best: 7 • Worst: 7	1 visits/month	$1.40 monthly value	8 days ago	Search Profile 🇸🇪 Sweden Mobile ALS: how close are we to a cure? /in-depth/als-cure-biotech-review/ 25 juni 2025 — The hunt for amyotrophic lateral sclerosis (ALS) drugs has advanced over the past decade, with six drugs approved by American regulators.
best longevity research 13 anti-aging biotech companies leading longevity in 2025 /best-biotech/anti-aging-biotech-companies/	7 Best: 7 • Worst: 7	—	—	9 days ago	Search Profile 🇸🇪 Sweden Mobile 13 anti-aging biotech companies leading longevity in 2025 /best-biotech/anti-aging-biotech-companies/ 27 okt. 2025 — Check out 13 anti-aging biotech companies looking to use longevity techniques to extend lives by halting or slowing the aging process.

labiotech.eu

Keyword rankings

We use cookies